Session Description:

This symposium will discuss some of the up-and-coming and non-traditional ways of using rtCGM in clinical practice – including pregnancy and in-patient hospital. Dr. Anku Mehta will share her clinical experience and benefits of using rtCGM in the UK during pregnancy with her T1 patients and vision for rtCGM beyond T1 diabetes and hopeful expanded reimbursement in the UK and globally. Dr. Eileen Faulds has been a true trail-blazer at the Ohio State University using rtCGM as the standard of glucose monitoring in the Medical ICU. Dr. Faulds will share the implementation of rtCGM with the Dexcom G6 into her institution for in-patient glucose monitoring, the validation process of rtCGM, best practices of using rtCGM for acute glycemic monitoring and acceptability of Dexcom G6 in the hospital by nursing and other in-patient staff. With the expanded use of Dexcom G6 under temporary enforcement discretion due to COVID-19 in the US and the recently received FDA Breakthrough Device Designation for Dexcom CGM use in the hospital setting, more institutions are looking to use rtCGM for inpatient glucose monitoring. Drs. Mehta and Faulds will share their wealth of practical clinical knowledge on these topics.